CCDC112 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.598180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.030200E-01
Normal-vs-Stage2
1.015210E-01
Normal-vs-Stage3
4.656200E-02
Normal-vs-Stage4
8.227000E-01
Stage1-vs-Stage2
3.699600E-01
Stage1-vs-Stage3
5.730400E-02
Stage1-vs-Stage4
6.925800E-01
Stage2-vs-Stage3
3.620000E-01
Stage2-vs-Stage4
1.854360E-01
Stage3-vs-Stage4
2.573600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.712440E-01
Normal-vs-AfricanAmerican
3.145600E-01
Normal-vs-Asian
1.105760E-01
Caucasian-vs-AfricanAmerican
7.722400E-01
Caucasian-vs-Asian
1.887620E-01
AfricanAmerican-vs-Asian
3.285800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.233200E-01
Normal-vs-Female
1.045760E-01
Male-vs-Female
4.956800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.989370E-01
Normal-vs-Age(41-60Yrs)
3.830400E-01
Normal-vs-Age(61-80Yrs)
1.036410E-01
Normal-vs-Age(81-100Yrs)
7.212300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.421000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.102800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.409600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.210000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.449000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.250200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.339800E-02
Normal-vs-Daily Drinker
3.696200E-02
Normal-vs-Weekly Drinker
1.664020E-01
Normal-vs-Occasional Drinker
5.791000E-01
Normal-vs-Social Drinker
4.605200E-01
Non Drinker-vs-Daily Drinker
4.906000E-01
Non Drinker-vs-Weekly Drinker
9.716600E-01
Non Drinker-vs-Occasional Drinker
1.759200E-01
Non Drinker-vs-Social Drinker
6.680300E-02
Daily Drinker-vs-Weekly Drinker
6.655000E-01
Daily Drinker-vs-Occasional Drinker
9.562400E-02
Daily Drinker-vs-Social Drinker
4.104100E-02
Weekly Drinker-vs-Occasional Drinker
2.736400E-01
Weekly Drinker-vs-Social Drinker
2.093000E-01
Occasional Drinker-vs-Social Drinker
9.951600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.206180E-01
Normal-vs-Grade 2
3.036300E-02
Normal-vs-Grade 3
3.425700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.551600E-01
Grade 1-vs-Grade 3
7.501200E-01
Grade 1-vs-Grade 4
1.206180E-01
Grade 2-vs-Grade 3
5.705200E-01
Grade 2-vs-Grade 4
3.036300E-02
Grade 3-vs-Grade 4
3.425700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.455170E-01
Normal-vs-NonDiabetic
1.397180E-01
Diabetic-vs-NonDiabetic
3.859600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.818400E-03
Normal-vs-NoPancreatitis
1.760990E-01
Pancreatitis-vs-NoPancreatitis
3.187700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.821600E-01
Normal-vs-N1
8.617700E-02
N0-vs-N1
3.468600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.648800E-01
Normal-vs-TP53-NonMutant
4.222600E-01
TP53-Mutant-vs-TP53-NonMutant
8.618600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
